Sanara MedTech Inc. (SMTI)
SMTI Stock Price Chart
Explore Sanara MedTech Inc. interactive price chart. Choose custom timeframes to analyze SMTI price movements and trends.
SMTI Company Profile
Discover essential business fundamentals and corporate details for Sanara MedTech Inc. (SMTI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
7 Apr 1994
Employees
141.00
Website
https://sanaramedtech.comCEO
Seth D. Yon
Description
Sanara MedTech Inc. is a Fort Worth, Texas-based company established in 2001, dedicated to the development, marketing, and distribution of advanced wound and skin care products. These solutions are provided to a diverse clientele within the United States healthcare sector, including physicians, hospitals, clinics, and post-acute care facilities. The company's extensive product portfolio includes CellerateRX, a line of Surgical Activated Collagen in both powder and gel forms, designed to enhance patient healing across various surgical specialties. Sanara MedTech also offers a suite of Biako's antimicrobial products: a patented Skin and Wound Cleanser engineered to dismantle mature biofilm microbes by disrupting their extracellular polymeric substances, an Antimicrobial Wound Gel effective against both planktonic and biofilm-forming microbes, and an Antimicrobial Skin and Wound Irrigation Solution. Another key offering is HYCOL, a hydrolyzed Type I bovine collagen available as powder and gel, specifically formulated for the management of both full and partial thickness wounds, encompassing conditions such as pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. Additionally, Sanara MedTech is involved in the development of sophisticated biologic devices like FORTIFY TRG, a freeze-dried, multi-layer sheet derived from small intestinal submucosa extracellular matrix, and FORTIFY FLOWABLE extracellular matrix, an innovative wound care solution. The company also provides VIM Amnion Matrix, a single-layer amnion tissue sheet. Initially incorporated as WNDM Medical Inc., the company underwent a name change to Sanara MedTech Inc. in May 2019.
SMTI Financial Timeline
Browse a chronological timeline of Sanara MedTech Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.07, while revenue estimate is $28.50m.
Earnings released on 11 May 2026
EPS came in at $0.04 surpassing the estimated -$0.04 by +200.00%, while revenue for the quarter reached $27.80m , beating expectations by +3.73%.
Earnings released on 24 Mar 2026
EPS came in at $0.04 falling short of the estimated $0.11 by -63.64%, while revenue for the quarter reached $27.55m , beating expectations by +0.53%.
Earnings released on 12 Nov 2025
EPS came in at $0.09 surpassing the estimated -$0.24 by +137.50%, while revenue for the quarter reached $26.33m , missing expectations by -3.18%.
Earnings released on 13 Aug 2025
EPS came in at -$0.23 surpassing the estimated -$0.33 by +30.30%, while revenue for the quarter reached $25.83m , missing expectations by -2.89%.
Earnings released on 14 May 2025
EPS came in at -$0.41 falling short of the estimated -$0.31 by -32.26%, while revenue for the quarter reached $23.43m , missing expectations by -5.89%.
Earnings released on 25 Mar 2025
EPS came in at -$0.18 surpassing the estimated -$0.19 by +5.26%, while revenue for the quarter reached $26.31m , beating expectations by +9.15%.
Earnings released on 12 Nov 2024
EPS came in at -$0.34 surpassing the estimated -$0.62 by +45.16%, while revenue for the quarter reached $21.67m , missing expectations by -3.25%.
Earnings released on 12 Aug 2024
EPS came in at -$0.41 falling short of the estimated -$0.21 by -95.24%, while revenue for the quarter reached $20.16m , beating expectations by +5.54%.
Earnings released on 13 May 2024
EPS came in at -$0.21 falling short of the estimated -$0.07 by -200.00%, while revenue for the quarter reached $18.54m , beating expectations by +0.20%.
Earnings released on 25 Mar 2024
EPS came in at -$0.03 surpassing the estimated -$0.13 by +76.92%, while revenue for the quarter reached $17.69m , beating expectations by +7.21%.
Earnings released on 13 Nov 2023
EPS came in at -$0.13 matching the estimated -$0.13, while revenue for the quarter reached $16.02m , missing expectations by -2.88%.
Earnings released on 14 Aug 2023
EPS came in at -$0.22 falling short of the estimated -$0.13 by -69.23%, while revenue for the quarter reached $15.75m , missing expectations by -6.79%.
Earnings released on 15 May 2023
EPS came in at -$0.20 surpassing the estimated -$0.33 by +39.39%, while revenue for the quarter reached $15.52m , missing expectations by -9.76%.
Earnings released on 20 Mar 2023
EPS came in at -$0.51 falling short of the estimated -$0.26 by -96.15%, while revenue for the quarter reached $15.32m , beating expectations by +3.49%.
Earnings released on 14 Nov 2022
EPS came in at -$0.18 surpassing the estimated -$0.32 by +43.75%, while revenue for the quarter reached $13.04m , missing expectations by -11.26%.
Earnings released on 15 Aug 2022
EPS came in at -$0.42 falling short of the estimated -$0.28 by -50.00%, while revenue for the quarter reached $9.67m , beating expectations by +11.16%.
Earnings released on 16 May 2022
EPS came in at -$0.41 , while revenue for the quarter reached $7.81m , beating expectations by 0.00%.
Earnings released on 30 Mar 2022
EPS came in at -$0.48 falling short of the estimated -$0.27 by -77.78%, while revenue for the quarter reached $7.03m , beating expectations by +15.30%.
Earnings released on 12 Nov 2021
EPS came in at -$0.27 falling short of the estimated -$0.18 by -50.00%, while revenue for the quarter reached $5.82m .
Earnings released on 16 Aug 2021
EPS came in at -$0.16 , while revenue for the quarter reached $6.28m , missing expectations by -74.06%.
SMTI Stock Performance
Access detailed SMTI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
